Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Goldberg eventually addressed the multiple interruptions in a message to viewers after a commercial break. "I'm working on ...
MOVING WALL The "moving wall" represents the time period between the last issue available in JSTOR and the most recently published issue of a journal. Moving walls are generally represented in years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results